Role of intracoronary adenosine on prevention of no reflow during Primary PCI in STEMI patients guided by MVO in CMR | ||||
| Cardiovascular Research Prove Journal | ||||
| Volume 6, Issue 2, December 2022 PDF (97.84 K) | ||||
| Document Type: Abstracts | ||||
| DOI: 10.21608/cvrepj.2022.351488 | ||||
 View on SCiNiTO | ||||
| Abstract | ||||
| Microvascular obstruction (MO) or no-reflow phenomenon is an established complication of coronary reperfusion therapy for acute myocardial infarction. | ||||
|
Statistics Article View: 68 PDF Download: 35 |
||||
